Free Trial
NASDAQ:DRIO

DarioHealth (DRIO) Stock Price, News & Analysis

DarioHealth logo
$0.67 0.00 (0.00%)
As of 04:00 PM Eastern

About DarioHealth Stock (NASDAQ:DRIO)

Key Stats

Today's Range
$0.67
$0.69
50-Day Range
$0.66
$0.82
52-Week Range
$0.50
$1.55
Volume
85,948 shs
Average Volume
285,484 shs
Market Capitalization
$29.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Moderate Buy

Company Overview

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

DRIO MarketRank™: 

DarioHealth scored higher than 38% of companies evaluated by MarketBeat, and ranked 749th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    DarioHealth has only been the subject of 1 research reports in the past 90 days.

  • Read more about DarioHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DarioHealth is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DarioHealth is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DarioHealth has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about DarioHealth's valuation and earnings.
  • Percentage of Shares Shorted

    7.50% of the float of DarioHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 13.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently increased by 2.07%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    DarioHealth does not currently pay a dividend.

  • Dividend Growth

    DarioHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.50% of the float of DarioHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    DarioHealth has a short interest ratio ("days to cover") of 13.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in DarioHealth has recently increased by 2.07%, indicating that investor sentiment is decreasing.
  • News Sentiment

    DarioHealth has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for DarioHealth this week, compared to 1 article on an average week.
  • Search Interest

    1 people have searched for DRIO on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DarioHealth insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.20% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 33.39% of the stock of DarioHealth is held by institutions.

  • Read more about DarioHealth's insider trading history.
Receive DRIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter.

DRIO Stock News Headlines

The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.
See More Headlines

DRIO Stock Analysis - Frequently Asked Questions

DarioHealth's stock was trading at $0.7861 at the start of the year. Since then, DRIO shares have decreased by 14.8% and is now trading at $0.67.
View the best growth stocks for 2025 here
.

DarioHealth Corp. (NASDAQ:DRIO) posted its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.14) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.07. The business had revenue of $6.75 million for the quarter, compared to the consensus estimate of $7.48 million. DarioHealth had a negative trailing twelve-month return on equity of 65.81% and a negative net margin of 159.80%.
Read the conference call transcript
.

DarioHealth subsidiaries include PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc..

Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA).

Company Calendar

Last Earnings
5/14/2025
Today
6/30/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:DRIO
Employees
200
Year Founded
2011

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+192.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$42.75 million
Net Margins
-159.80%
Pretax Margin
-159.22%

Debt

Sales & Book Value

Annual Sales
$27.04 million
Price / Cash Flow
N/A
Book Value
$2.11 per share
Price / Book
0.32

Miscellaneous

Free Float
39,484,000
Market Cap
$30.37 million
Optionable
Optionable
Beta
1.58

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:DRIO) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners